glp 1/gip agonist New strategies for the treatment of obesity and metabolic dysfunctions Emerging Role of Dual GLP-1
Description
doi: 10.1016/j.ejphar.2021.174310 47 HansenDVHansonJEShengM
Hiromura, M
10.1016/j.molmet.2019.09.010
Long-Term Results : Saxenda can be used for an extended period, allowing individuals to maintain their weight loss and develop healthier habits over time
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
These symptoms often improve with time as the body adjusts
